Yeji
FDA approvaloutcome: successconf 1.00

imcivree — FDA approval

$RYTM · RHYTHM PHARMACEUTICALS, INC.
Event date
June 16, 2022
1451 days ago
Sponsor runway
23 mo
$340.6M liquid

Evidence

openFDA SUPPL (EFFICACY) approval of IMCIVREE — application NDA213793

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)
TickerDrugDateOutcome
$INCYzynyz2026-05-18success
$INCYjakafi xr2026-05-01success
$AXSMauvelity2026-04-30success
$INCYzynyz2026-03-30success
$BIIBspinraza2026-03-27success
$CORTlifyorli2026-03-25success
$RYTMimcivree2026-03-19success
$ASNDyuviwel2026-02-27success
$BMRNpalynziq2026-02-27success
$ETONdesmoda2026-02-25success

Recent insider activity· ±90 days

10 insiders · 0 buys · 4 sells
Exercise
2022-08-19
Cramer Pamela J.
Chief Human Resources Officer
13,493 @ $19.02$257K
Sell
2022-08-19
Cramer Pamela J.
Chief Human Resources Officer
13,493 @ $24.83$335K
Sell
2022-07-27
Cramer Pamela J.
Chief Human Resources Officer
901 @ $11.68$11K
Exercise
2022-07-26
Cramer Pamela J.
Chief Human Resources Officer
3,125 @
Sell
2022-07-01
Smith Hunter C
Chief Financial Officer
7,547 @ $4.08$31K
Exercise
2022-06-30
Smith Hunter C
Chief Financial Officer
25,000 @
Grant
2022-06-08
Bedrosian Camille L
Director
20,000 @
Grant
2022-06-08
TETRAULT LYNN A.
Director
20,000 @
Grant
2022-06-08
JEAN CHRISTOPHE
Director
20,000 @
Grant
2022-06-08
GOOD JENNIFER L
Director
20,000 @
Grant
2022-06-08
MCGIRR DAVID W J
Director
20,000 @
Grant
2022-06-08
Mathers Edward T
Director
20,000 @
Grant
2022-06-08
Arbuckle Stuart A
Director
20,000 @
Exercise
2022-03-29
Roberts William T.
Chief Accounting Officer
2,500 @
Sell
2022-03-29
Roberts William T.
Chief Accounting Officer
1,023 @ $11.13$11K